For routine GLP-1 management - tolerability updates, dose titration requests, refill management - that model works well for most patients
More than 70% of patients taking GLP-1 medications reported reduced alcohol cravings, a decreased desire to drink, a reduction in how much alcohol they drink per week, fewer drinks per drinking session, and reduced binge drinking compared to prior to starting treatment compared to the control group that was not taking GLP-1 medications
Ulodesine (BCX4208) long-term safety when added to allopurinol in the chronic management of gout: A Phase 2 24-Week Blinded Safety Extension and Vaccine Challenge Study [abstract]
Steaming, boiling, and stewing may be safer cooking methods
The issue is whether the monitoring and support framework around the prescription matches what this age group needs
Our Semaglutide injection program typically involves weekly injections administered over a period of several months